Schizophrenia (SZ) and bipolar disorder (BPD) are two severe psychiatric diseases with a strong genetic component. In agreement with the 'continuum theory', which suggests an overlap between these disorders, the existence of genes that affect simultaneously susceptibility to SZ and BPD has been hypothesized. In this study we performed a 7.5 cM genome scan in a sample of 16 families affected by SZ and BPD, all originating from the same northeast Italian population. Using both parametric and non-parametric analyses we identified linkage peaks on four regions (1p, 1q, 4p and 15q), which were then subjected to a follow-up study with an increased marker density. The strongest linkage was obtained on chromosome 15q26 with a non-parametric linkage of 3.05 for marker D15S1014 (nominal P = 0.00197). Interestingly, evidence for linkage with the same marker has been reported previously by an independent study performed on SZ and BPD families from Quebec. In this region, the putative susceptibility gene ST8SIA2 (also known as SIAT8B) was recently associated with SZ in a Japanese sample. However, our allele frequency analyses of the two single-nucleotide polymorphisms (SNPs) with putative functional outcome (rs3759916 and rs3759914) suggest that these polymorphisms are unlikely to be directly involved in SZ in our population. In conclusion, our results support the presence of a gene in 15q26 that influences the susceptibility to both SZ and BPD.
Introduction
Schizophrenia (SZ) and bipolar disorder (BPD) are two severe and debilitating mental disorders. SZ is characterized by delusions, hallucinations and difficulties in performing everyday activities and inappropriate display or total lack of emotions; on the other hand, BPD is a distinct neuropsychiatric illness characterized by a significant mood disturbance with a recurrent alternation of elevated and low moods. Together these illnesses represent one of the top 10 causes of disability in the world, each of them affecting about 1% of the human population and presenting a frequency of suicide among the affected individuals of about 10%. 1 Several studies confirm the genetic component in their etiology: family, twin and adoption studies evidence a high heritability (up to 80%) and it is widely accepted that many genes and environmental factors contribute to their predisposition. 2, 3 Traditionally, according to 'Kraepelinian dichotomy' SZ and BPD have been classified as two distinct clinical entities and most of the clinical, epidemiological and genetic studies have been carried out maintaining this rigorous classification. 4 More recently, an alternative approach based on a continuum in which SZ and BPD overlap with the affective spectrum, has been considered in psychiatric research. 5, 6 According to this model, the genetic component could be conceptualized as a set of susceptibility genes conferring risk along different domains of the spectrum. In other words, some genes would be specific for SZ, others for BPD and others would simultaneously confer risk across the spectrum. 5 Whole-genome linkage studies for SZ and BPD have identified significant linkage signals on several chromosome regions and some of them (13q, 22q, 18 and 6q) clearly overlap in both disorders. 7 In addition, several association and expression studies supported the involvement of the same genes in SZ and BPD, including DAOA, DISC1, NRG1, COMT 7 and GRK3, 33 further supporting the genetic convergence between these psychiatric disorders.
In the past 2 years, linkage studies tried to identify susceptibility genes shared by SZ and BPD using different approaches: Sklar et al. 8 studied the occurrence of psychosis in SZ and BPD families and reported evidence for linkage on chromosome 5q, whereas using similar diagnostic criteria in BPD pedigrees Park et al. 9 and Cheng 10 reported significant logarithm of odds (LOD) scores in 9q31 and 8p21, and in 16p12.3, respectively. Moreover, a genome-wide search in families that were ascertained through a proband with schizoaffective disorder (SCA) (a form of illness with features of both SZ and BPD), was performed by Hamshere, 11 who reported a significant linkage at 1q42. Finally, by combining SZ and BPD families Maziade et al.
12 identified significant linkage peaks on chromosomes 18q and 15q26. In several of these loci association studies identified putative common susceptibility genes, such as DISC1 on chromosome 1q42, 13 FZD3 14 and NRG1 15 on 8p2, Epsin 4 17, 18 and GABAA receptor 19 on chromosome 5q. In addition, a new gene, ST8SIA2 (also known as SIAT8B), which maps on chromosome 15q26, has been recently associated with SZ in a Japanese sample. Interestingly, this gene has been identified by a positional-independent approach, considering its functional involvement in the neuronal development via modification of the neural cell adhesion molecule 1 (NCAM1) molecule. 16 Among the genes reported above, a number of studies have reported positive association with SZ and BPD only for DISC1 20,21 and NRG1, 22, 23 whereas the involvement of the other genes in both disorders is still uncertain.
These findings could help unraveling the overlap between SZ and BPD, but their replication in other populations by independent groups is required to assess their validity. The number of regions involved in SZ and BPD by linkage studies and the failure in replicating most of them suggests the existence of a wide genetic heterogeneity and raises the concern about studying samples of different ethnic origin. Several reports suggest that using samples from small populations could decrease allelic and locus heterogeneity; besides, the variability owing to environmental, cultural and life style factors would also be lower than in large and mixed populations. 24 In this study we present the results of a genomewide scan and a follow-up study aimed at localizing susceptibility genes shared by SZ and BPD in a set of families originating from the population of Chioggia, a town located in an island of the Venetian lagoon.
Materials and methods

Sample collection and ascertainment
The Medical Ethic Committee of Chioggia in accordance with the current legislation approved the present study, as well as the sample collection procedures. All subjects were interviewed by an expert psychiatrist, informed consent was obtained for each participant and affected subjects were diagnosed according to Diagnostic and Statistical Manual (DSM)-IV criteria.
In addition all patients have been hospitalized and medical records were available for all of them. The initial diagnosis was then reviewed and confirmed by a second psychiatrist using all data available such as interviews, lifetime medical and psychiatric information. Families were ascertained through probands affected by SZ spectrum disorders, bipolar spectrum disorders (BPD) or SCA and were included in the study in case at least an additional member of the family (first or second-degree relative) met DSM-IV criteria for SZ, BPD or SCA.
The sample included a total of 57 subjects available for genotyping; among them 51 individuals (26 females and 25 males) were diagnosed as follows: 33 SZ, 14 BPD and four SCA. Based on clinical assessment the families could be classified into: seven SZ (with only SZ patients), two BPD (with only BPD patients) and seven mixed pedigrees (with SZ þ BPD, SZ þ SCA or SZ þ BPD þ SCA patients).
Considering the whole sample, 16 different pedigrees were studied: nine nuclear families (seven siblings pairs, one sibling trio and one sibling quartet), two families including half-sibs, one family with avuncular pairs and three extended families (containing eight, seven and five affected subjects, respectively) with two or more sibships and complex relationships.
For each family, pedigree structure was traced confidentially by a genealogist back to four/five generations using both church registers and demographical records. For all the families their origin from the old Chioggia population was confirmed and no inter-family marriage or inbreeding loops were found in the sample.
Using the same approach, a group of 50 healthy subjects all originating from Chioggia and unrelated to each other and the family sample was collected. In addition a second sample of 50 unrelated healthy subjects randomly chosen from the wide Italian population (defined as non-Chioggia sample) was available for the study. Controls from Chioggia were used to derive appropriate markers alleles frequencies for linkage analysis (see linkage analysis section) and to test allele frequencies of single-nucleotide polymorphism (SNPs) in ST8SIA2 gene (see SNPs analysis on ST8SIA2 gene section); the last analysis was also carried out in the non-Chioggia sample.
Genotyping
Blood samples were collected from all participants and DNA was isolated using a standard phenolchloroform extraction procedure. The genome-wide scan was performed using a set of 465 autosomal microsatellites including 382 markers from the ABI Prism Linkage Mapping Set, MD-10 and additional 83 markers chosen from the Linkage Mapping Set, MD-5. Overall the average marker spacing was 7.5 cM with an average heterozigosity of 0.75.
Polymerase chain reaction (PCR) amplifications were performed under standard conditions using appropriate primers with fluorescent dye (FAM, HEX and NED). PCR products were then pooled into multiplex panels and separated on an ABI PRISM 3700 DNA Sequencer (Applied Biosystems, Foster City, CA). Genotypes were assigned by two expert readers using GeneScan v2.0 and Genotyper v2.0 software (Applied Biosystem).
In chromosomal regions showing a non-parametric linkage (NPL) > 1.5 in the first scan (i.e. 1p, 1q and, 15q) we carried out a follow-up study using a denser marker map. Microsatellites were chosen from the UCSC Human Genome Database given priority to markers with the highest heterozygosity. Overall 24 additional markers (D1S434, D1S228, D1S507, D1S2672, D1S436, D1S1592, D1S2644, D1S229, D1S2833, D1S251, D1S2709, D1S2850, D1S409, D4S2912, D4S1587, D4S2971, D4S428, D15S207, D15S657, D15S1014, D15S212, D15S966, D15S203 and N15S1Q) were genotyped in all the families using the same procedure described previously. Marker N15S1Q is a new polymorphic dinucleotyde repeat that we identified starting at position 99425150 on chromosome 15q26. It was amplified using primers 5 0 -GCCAGTCTCCTCTGTGAAGG-3 0 and 5 0 -TCCACCC TCTTATGCTCCAG-3 0 under standard PCR conditions. The marker's order and genetic distances were based on the UCSC Human Genome Database (http://genome.ucsc.edu, hg17 release) and on the genetic Rutgers map (http://compgen.rutgers.edu/ maps/, build 34). 25 Linkage analysis statistical methods Errors in the allele calling were checked using PedCheck program 26 and mendelian inconsistencies were resolved; the overall error rate was very low and was estimate in about 0.25%. Considering this data we performed genome-wide linkage study using a multipoint approach that is theoretically more sensitive to genotyping errors but in contrast more powerful and less prone to random stochastic fluctuation than single point. 27 Genome-wide analysis was performed with Genehunter version 2.1 28 using both parametric and model-free statistical methods. To minimize the error owing to multiple testing, heterogeneity parametric LOD scores (HLOD) were calculated under one simple dominant and one recessive model.
According to the multidimensional model for these psychiatric illnesses, we used a single affection status definition grouping together patients with SZ, BPD and SCA phenotypes.
This analysis was conducted using an 'affected only approach' thus coding as phenotype 'unknown' all the unaffected relatives. For both the models a phenocopy rate of 0.01 was assumed and the disease allele frequency was set at 0.01 and 0.15 for dominant and recessive models, respectively. NPL analysis was performed using the S all statistic that looks for excess allele sharing combining information from all affected subjects within a pedigree.
In the genome-wide linkage analysis, markers allele frequencies were estimated from the entire sample using the quasi likelihood method implemented in CC-QLS (case-control quasi-likelihood score test) program that take into account the kinship between subjects of the same family. 29 In the candidate regions, allele frequencies of all the markers were directly estimated from the sample of 50 unrelated controls from Chioggia. No statistically significant differences were found between frequencies derived from the family sample and those obtained from the sample of controls.
To establish the genome-wide empirical threshold, 100 replicates of whole genome scan were simulated under the hypothesis of no linkage using Merlin program. 30 Each replicate matched the observed data set in family structure, marker map, alleles frequencies and missing data etc. Each replicate was then analyzed with Genehunter and empirical genomic P-value was obtained evaluating the false positive rate of a given LOD score. For the follow-up study empirical thresholds were re-computed using the same procedure and incorporating the new markers analyzed.
SNPs analysis on ST8SIA2 gene
The allele frequencies distribution of two SNPs (SNPs 1: À1126T > C, rs3759916 and SNP3: À851T > C, rs3759914) located in the promoter region of the gene ST8SIA2 and directly associated to SZ in a Japanese sample was evaluated in the Chioggia and nonChioggia control samples.
Genotyping was performed by PCR amplification and direct sequencing of a fragment containing both SNPs. PCR reactions were performed under standard conditions using the primers 5 0 -AGGACATTCCATGT AGCTTCTCCAA-3 0 and 5 0 -CCAGGTGCTGATCTTTA TCTCCATTT-3 0 . Sequencing was carried out on an ABI PRISM 3100 Genetic Analyzer using the Big Dye terminator chemistry.
Results
Multipoint parametric and non-parametric LOD scores obtained from the 7.5 cM genome scan are presented in Figure 1 .
As shown by the NPL and HLOD plots, our findings are quite concordant for positive chromosomal regions. The parametric analysis seems less powerful than NPL, probably because of the sensitiveness of the multipoint analysis to the misspecification of the inheritance models. For this reason, we focused our attention on NPL statistics for P-value estimation.
According to our genome-wide simulations, the NPL threshold for 'suggestive' linkage was 2.1. As none of the initial linkage signals reached this value, we chose to analyze additional markers in the regions exceeding the arbitrary threshold of NPL > 1.5.
Overall, four regions met these criteria and were selected for the follow-up study: chromosome 1p36 (NPL = 1.69 at marker D1S2697), 1q43 (NPL = 1.51 at marker D1S2842), 4p14 (NPL = 1.71 for marker D4S405) and 15q26 (NPL = 1.93 for marker D15S120). All families were then genotyped with a total of 24 additional markers (seven for chromosome 1p, six in 1q, four in 4p and seven in 15q), achieving an average intermarker distance in these regions of 1.9, 3.5, 4.0 and 2.4 cM, respectively.
Both initial and follow-up NPL results for chromosomes 1, 4 and 15 are reported on panels in Figure 2 . Overall, NPL on chromosome 1p weakly increased from 1.69 to 1.89, whereas on regions 1q and 4p we observed weakened linkage signals (with a NPL value decreasing from 1.51 to 1.38 and from 1.71 to 1.54, respectively) ( Figure 2 ). The best score was obtained on chromosome 15q, with a NPL strongly increasing from 1.93 up to 3.05 (Table 1) . Positive values in the same region were also observed by parametric analysis, yielding a maximum recessive HLOD of 2.43 (alpha = 0.91) and a dominant HLOD of 2.12 (alpha = 0.82).
Genome-wide simulations were carried out once more, using the denser marker set. Results suggested that a NPL of 2.2 could be considered suggestive for linkage, whereas a NPL of 3.15 was needed to establish significant linkage. Based on these thresholds, linkage peaks on chromosome 1 and 4 fell into 'background signals', whereas our results on chromosome 15 met the statistical criteria for suggestive linkage (genomic P-value = 0.07).
The highest NPL score on chromosome 15q26 was observed at position 117 cM, close to markers D15S1014 and D15S212. Assuming max NPL-1 as the approximation of the 95% confidence interval (CI), the critical region spanned about 15 cM (from 107 to 122 cM) and was flanked by the external markers D15S130 and D15S203.
A thorough inspection of the LOD scores by family evidenced that the linkage signal on chromosome 15q26 was supported by almost all the families (14/16 pedigrees showed increased allele sharing in this region), with a contribution of both BPD, SZ and mixed families.
ST8SIA2 gene analysis
The ST8SIA2 gene, which has been recently associated to SZ in the Japanese population, maps on chromosome 15q26, about 5 Mb proximally to our linkage peak.
Even though the gene is located slightly outside of our 95% CI, it remains a plausible candidate on the basis of its functional features and the published association study. We then performed a preliminary analysis to obtain the frequencies of the two SZassociated SNPs in the population of Chioggia (SNPs 1: À1126T > C, rs3759916 and SNP3: À851T > C, rs3759914). In addition, we also genotyped 50 healthy subjects coming from other Italian regions, in order to evaluate the allele distribution of these SNPs in the general Italian population. As reported in Table 2 , no differences were observed between the two samples. In both cases, SNP1 resulted to be a rare polymorphism (minor allele frequency (MAF), lower than 5%), whereas for SNP3 only one allelic variant (T allele) was detected in all 100 subjects analyzed.
A preliminary analysis was also carried out in the index cases of the family sample, showing comparable allele frequencies with the control groups.
Discussion
Our study presents a genome-wide search and a follow-up linkage study on a sample of families originating from Chioggia, a town in an island of the Venetian lagoon with a current population of 52,000. Based on its history, geographical position and social aspects, the population of Chioggia can be considered a culturally 'closed' community, characterized by a low number of family names. 31 This latter peculiarity, which seems to reflect the low migration and high endogamy of the town, suggests that the affected individuals may share a small number of susceptibility alleles.
Following the hypothesis of a genetic overlap between SZ and BPD, in this study we included families with SZ, families with BPD as well as families in which SZ, BPD and SCA occurred together in the same pedigree.
A preliminary 7.5 cM autosomal scan detected weak linkage peaks in four regions (1p, 1q, 4p and 15q), which were then subjected to a follow-up study with an increased marker density.
Overall, the best evidence of linkage was observed on a region of about 12 cM on chromosome 15q26, with a peak of NPL of 3.05 (nominal P = 0.00197). These findings were also supported by the parametric analysis that yielded a maximum HLOD of 2.43 (alpha = 0.91, under a recessive model of inheritance).
These results should be taken into consideration even if the maximum NPL does not reach the threshold for significance (genomic P-value of 0.07), as other groups reported evidence for linkage in the same region. In particular, in a study aiming at identifying susceptibility genes shared by SZ and BPD, Park et al. 9 reported a suggestive multipoint NPL of 2.62 for maker D15S652 in BPD families that had been reclassified on the basis of the presence of psychotic features. More recently, a genome-wide search on a set of 21 multigenerational families from the Eastern Quebec population affected by SZ, BPD qor both disorders was carried out by the group of Maziade et al. 12 Using a 'common locus' phenotype Abbreviation: NPL, non-parametric linkage. Additional markers used for the follow-up study are in bold.
Marker location on genetic map are given according to the Rutgers genetic map. Nominal P-value are calculated by GENEHUNTER program and are referred to markers after follow-up study. Following the Lander and Kruglyak 32 criteria, a nominal P-value of 1 Â 10 À2 is needed in order to replicate linkage in a region that received significant scores in a previous genome-wide search. Considering the findings reported by Maziade et al., our results for marker D15S1404 (P-value of 0.00197) confirm the linkage in 15q26. Moreover, nominal P-values < 0.01 were observed for three additional consecutive markers flanking the D15S1014 (D15S112 P = 0.0023, D15S966 P = 0.0059 and D15S120 P = 0.0081). It is important to notice that the statistical significance of our data was not hampered by the relatively small size of our sample, as we applied empirical P-values and statistical thresholds via simulation. Also, we chose a multipoint approach, rather than the single point one, as the former is less sensitive to false positives.
Despite the many genome-wide searches for SZ or BPD published so far, it is intriguing to notice that only the studies designed to identify genes shared by SZ and BPD could find linkage signals on chromosome 15q26. 9, 12 Indeed, our confirmatory linkage on locus 15q26 has also been obtained using a 'common locus' model similar to that adopted by Maziade et al. Altogether, our findings suggest that investigating SZ, BPD and SCA families in the same study may be a valid approach, particularly when dealing with samples with a common ethnic origin.
The fact that many studies failed to find interesting linkage signal on chromosome 15q26 8, 10, 11 could be ascribed to the high locus heterogeneity that characterize SZ and BPD. However, it should be noted that the 15q26 region is near to the telomere and therefore the final result of a linkage analysis can be deeply affected by markers analyzed. For instance, the most telomeric marker used by Sklar et al. 8 for the long arm of chromosome 15 (D15S675) was centromeric to our linkage peak; had we not used more telomeric markers, in the first scan we would have obtained a NPL of 1.4, which would have been not considered eligible for subsequent study. This observation raises the issue of comparing genome-wide scan results obtained with different markers sets and supports the relevance of using appropriate markers to replicate previous findings. This factor should be taken into consideration especially when analyzing telomeric regions, in which the presence of recombination hot spots can affect the linearity between physical and genetic maps.
The other regions highlighted in our genome scan (i.e. 1p36 and 1q43) did not yield significant data in our follow-up study; yet, they showed suggestive overlap with loci reported by other studies. Namely, the peak on chromosome 1q is close to the DISC1 gene and the 1p region is slightly distal to the MTHR gene, which has been recently associated both to SZ and BPD. 34 These findings seem to support the role of these genes as common susceptibility factors to SZ and BPD, however they have to be interpreted with caution given their low statistical significance.
Recently, Arai et al. 16 identified a new gene in the proximity of our linkage peak in 15q26, named ST8SIA2, which has been indicated as a possible susceptibility gene for SZ. The gene codes for a poly-sialil-tranferase that catalyzes the transfer of poly-sialic acid (PSA) to the NCAM1. Interestingly, the authors considered ST8SIA2 a good candidate gene using a functional approach, as PSA-dependent modification of NCAM1 plays an important role in neuronal development and the perturbation of this process might therefore be an etiologic factor for psychiatric disorders. In a case-control study performed on a Japanese sample the Authors identified significant allelic association for two SNPs (SNPs 1: À1126T > C, rs3759916 and SNP3: À851T > C, rs3759914) located in the promoter of the ST8SIA2 gene. Moreover, an in vitro promoter assay performed to evaluate the functional role of these SNPs showed an increased transcriptional activity of the risk-conferring haplotype, suggesting an involvement of the SNP1-T and SNP3-T alleles in the developing SZ. As no data are reported in the dbSNP database (http://www. ncbi.nlm.nih.gov/SNP) about alleles frequencies of these SNPs in the European population, we performed a preliminary analysis on their frequencies in a sample of 100 Italian subjects (50 individuals from Chioggia and 50 randomly chosen from other Italian regions). The SNPs analyzed resulted to be rare (SNP1) or not polymorphic at all (SNP3), both in Chioggia and in the general Italian population. This means that whereas SNP3 could not be used for association studies, for SNP1 a sample of over 2000 cases and 2000 controls it would be required to detect significant association in the Italian population (and probably also in the European population; data calculated with Power Calculator program assuming MAF of 0.03, power of 70% and relative risk 1.5). Moreover, the alleles of the at-risk haplotype with putative functional outcome in the Japanese sample (SNP1-T and SNP3-T) are unlikely to be directly involved in SZ in our population, as these variants are the most common ones in the 100 healthy subjects analyzed (SNP1-T f = 0.98, SNP3-T f = 1.00). The association with the ST8SIA2 gene cannot be excluded, but further studies with different SNPs across the gene and on a larger sample will be required.
In summary, here we described a genome-wide search in a small but significant set of families with subjects affected by SZ, BPD and SCA. Further analyses of positive regions supported evidence for linkage on chromosome 15q26. These results, together with the results from other independent studies, strongly support the presence in this region of a gene that influences the susceptibility to both SZ and BPD. This would be in agreement with the hypothesized existence of susceptibility genes that affect the clinical spectrum of functional psychoses.
